HPV vaccine long-term effect study for young adults
Part of Infections clinical trials.
This study checks if one dose of the 9-valent HPV vaccine given at ages 9-11 still protects you 6 years later. It is for people who only had that single dose and no other HPV shots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received one dose of 9-valent HPV vaccine when you were 9-11 years old.
- You did not get any other HPV vaccine doses before or after.
- You are able to give your own permission to join the study.
- You do not have a condition that weakens your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the safety and immune response of a 9-valent HPV vaccine. It is for women who have already received a full course of certain HPV vaccines and are now getting a different one to see if it boosts their immunity.
This trial tests a new 15-valent HPV vaccine to see if it is safe and creates a strong immune response. If you are between 9 and 45 years old and have not had an HPV vaccine before, you may be able to join.
This trial tests a new vaccine called V540B that targets HPV, a common virus linked to certain cancers. The study aims to see if the vaccine is safe and produces a strong immune response in healthy people.
This study tests whether a single dose of the HPV vaccine is enough to protect against the viruses that cause several cancers. You will have the vaccine and some small tissue samples taken to see how your immune system responds.
This study checks how well the HPV (cancer-preventing) vaccine protection stays in your body over time. It may help confirm the vaccine’s “long-lasting” immune response and guide future vaccination confidence.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
Hear when a new HPV Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.